Administration of non-torsadogenic human Ether-à-go-go Related Gene inhibitors is associated with better survival for high hERG-expressing glioblastoma patients

Por Pointer, Kelli B., Clark, Paul A., Eliceiri, Kevin W., Salamat, M. Shahriar, Robertson, Gail A., Kuo, John S.
Publicado no Clin Cancer Res (2016)

Hematopoietic- and Neurologic-Expressed Sequence 1 Expression in the Murine GL261 and High-Grade Human Gliomas

Por Laughlin, Katharine M., Luo, Defang, Liu, Che, Shaw, Gerry, Warrington, Kenneth H., Qiu, Jingxin, Yachnis, Anthony T., Harrison, Jeffrey K.
Publicado em 2009

Real-time hemodynamic response and mitochondrial function changes with intracarotid mannitol injection

Por Joshi, Shailendra, Singh-Moon, Rajinder, Wang, Mei, Bruce, Jeffrey N., Bigio, Irving J., Mayevsky, Avraham
Publicado em 2014

Candesartan reduces the hemorrhage associated with delayed tissue plasminogen activator treatment in rat embolic stroke

Por Ishrat, Tauheed, Pillai, Bindu, Ergul, Adviye, Hafez, Sherif, Fagan, Susan C
Publicado em 2013

The effects of CEP-37440, an inhibitor of focal adhesion kinase, in vitro and in vivo on inflammatory breast cancer cells

Por Salem, Israa, Alsalahi, Manal, Chervoneva, Inna, Aburto, Lucy D., Addya, Sankar, Ott, Gregory R., Ruggeri, Bruce A., Cristofanilli, Massimo, Fernandez, Sandra V.
Publicado no Breast Cancer Res (2016)

Early gestational mesenchymal stem cell secretome attenuates experimental bronchopulmonary dysplasia in part via exosome-associated factor TSG-6

Por Chaubey, Sushma, Thueson, Sam, Ponnalagu, Devasena, Alam, Mohammad Afaque, Gheorghe, Ciprian P., Aghai, Zubair, Singh, Harpreet, Bhandari, Vineet
Publicado no Stem Cell Res Ther (2018)

MiR-32 Inhibits Proliferation and Metastasis by Targeting EZH2 in Glioma

Por Zhang, Yuan, Wang, Jiangang, An, Wenzhi, Chen, Chen, Wang, Wencheng, Zhu, Chao, Chen, Fangzhou, Chen, Huizhao, Zheng, Wei, Gong, Jie
Publicado no Technol Cancer Res Treat (2019)

Palliative radiation therapy in patients with metastasized pancreatic cancer - description of a rare patient group

Por Habermehl, Daniel, Brecht, Ingo C, Debus, Jürgen, Combs, Stephanie E
Publicado em 2014

Identifying Voxels at Risk for Progression in Glioblastoma Based on Dosimetry, Physiologic and Metabolic MRI

Por Anwar, Mekhail, Molinaro, Annette M., Morin, Olivier, Chang, Susan M., Haas-Kogan, Daphne A., Nelson, Sarah J., Lupo, Janine M.
Publicado no Radiat Res (2017)

Involvement of miR-Let7A in inflammatory response and cell survival/apoptosis regulated by resveratrol in THP-1 macrophage

Por Song, Juhyun, Jun, Mira, Ahn, Mok-Ryeon, Kim, Oh Yoen
Publicado no Nutr Res Pract (2016)

Autocrine Glutamate Signaling Promotes Glioma Cell Invasion

Por Lyons, Susan A., Joon Chung, W., Weaver, Amy K., Ogunrinu, Toyin, Sontheimer, Harald
Publicado em 2007

MSH6 mutations arise in glioblastomas during temozolomide therapy and mediate temozolomide resistance

Por Yip, Stephen, Miao, Jiangyong, Cahill, Daniel P., Iafrate, A. John, Aldape, Ken, Nutt, Catherine L., Louis, David N.
Publicado em 2009

Halofuginone inhibits the establishment and progression of melanoma bone metastases

Por Juárez, Patricia, Mohammad, Khalid S., Yin, Juan Juan, Fournier, Pierrick GJ., McKenna, Ryan C., Davis, Holly W., Peng, Xiang H., Niewolna, Maria, Javelaud, Delphine, Chirgwin, John M., Mauviel, Alain, Guise, Theresa A.
Publicado no Cancer Res (2012)

BRAF inhibitor and stereotactic radiosurgery is associated with an increased risk of radiation necrosis

Por Patel, Kirtesh R., Chowdhary, Mudit, Switchenko, Jeffrey M., Kudchadkar, Ragini, Lawson, David H., Cassidy, Richard J., Prabhu, Roshan S., Khan, Mohammad K.
Publicado no Melanoma Res (2016)

Trifluoperazine, a novel autophagy inhibitor, increases radiosensitivity in glioblastoma by impairing homologous recombination

Por Zhang, Xin, Xu, Ran, Zhang, Chao, Xu, Yangyang, Han, Mingzhi, Huang, Bin, Chen, Anjing, Qiu, Chen, Thorsen, Frits, Prestegarden, Lars, Bjerkvig, Rolf, Wang, Jian, Li, Xingang
Publicado no J Exp Clin Cancer Res (2017)

The Cytocidal Activity of OK‐432‐activated Mononuclear Cells against Human Glioma Cells is Partly Mediated through the Fas Ligand/Fas System

Por Toda, Keisuke, Shiraishi, Tetsuya, Hirotsu, Tatsumi, Fukuyama, Kouzou, Mineta, Toshihiro, Kawaguchi, Shojiro, Tabuchi, Kazuo
Publicado no Jpn J Cancer Res (1996)

Morphological Differentiation Towards Neuronal Phenotype of SH-SY5Y Neuroblastoma Cells by Estradiol, Retinoic Acid and Cholesterol

Por Teppola, Heidi, Sarkanen, Jertta-Riina, Jalonen, Tuula O., Linne, Marja-Leena
Publicado no Neurochem Res (2015)

HIV-1 Tat-induced microglial activation and neuronal damage is inhibited via CD45 modulation: A potential new treatment target for HAND

Por Jin, Jingji, Lam, Lucy, Sadic, Edin, Fernandez, Frank, Tan, Jun, Giunta, Brian
Publicado em 2012

Differential Expression of 2’,3’-Cyclic-Nucleotide 3’-Phosphodiesterase and Neural Lineage Markers Correlate with Glioblastoma Xenograft Infiltration and Patient Survival

Por Zorniak, Michael, Clark, Paul A., Leeper, Heather E., Tipping, Matthew D., Francis, David M., Kozak, Kevin R., Salamat, M. Shahriar, Kuo, John S.
Publicado em 2012

Dual-targeting of aberrant glucose metabolism in glioblastoma

Por Shen, Han, Decollogne, Stephanie, Dilda, Pierre J, Hau, Eric, Chung, Sylvia A, Luk, Peter P, Hogg, Philip J, McDonald, Kerrie L
Publicado no J Exp Clin Cancer Res (2015)